J. A. Fishman, Infection in solid-organ transplant recipients, N Engl J Med, vol.357, pp.2601-2614, 2007.

S. Euvrard, E. Morelon, L. Rostaing, E. Goffin, A. Brocard et al., Sirolimus and secondary skin-cancer prevention in kidney transplantation, N Engl J Med, vol.367, pp.329-339, 2012.

J. D. Scandling, S. Busque, S. Dejbakhsh-jones, C. Benike, M. T. Millan et al., Tolerance and chimerism after renal and hematopoietic-cell transplantation, N Engl J Med, vol.358, pp.362-368, 2008.

J. Leventhal, M. Abecassis, J. Miller, L. Gallon, K. Ravindra et al., Chimerism and tolerance without GVHD or engraftment syndrome in HLAmismatched combined kidney and hematopoietic stem cell transplantation, Sci Transl Med, vol.4, pp.124-152, 2012.

T. Kawai, D. H. Sachs, B. Sprangers, T. R. Spitzer, S. L. Saidman et al., Longterm results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression, Am J Transplant, vol.14, pp.1599-1611, 2014.

E. K. Geissler and J. A. Hutchinson, Cell therapy as a strategy to minimize maintenance immunosuppression in solid organ transplant recipients, Curr Opin Organ Transplant, vol.2013, pp.1-8

Q. Tang and J. A. Bluestone, Regulatory T-cell therapy in transplantation: moving to the clinic, Cold Spring Harb Perspect Med, vol.3, p.15552, 2013.

P. Sagoo, N. Ali, G. Garg, F. O. Nestle, R. I. Lechler et al., Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells, Sci Transl Med, vol.3, pp.83-125, 2011.

A. B. Farris, D. Taheri, T. Kawai, L. Fazlollahi, W. Wong et al., Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts, Am J Transplant, vol.11, pp.1464-1477, 2011.

D. H. Sachs, M. Sykes, T. Kawai, and A. B. Cosimi, Immuno-intervention for the induction of transplantation tolerance through mixed chimerism, Semin Immunol, vol.23, pp.165-173, 2011.

A. L. Putnam, N. Safinia, A. Medvec, M. Laszkowska, M. Wray et al., Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation, Am J Transplant, vol.13, pp.3010-3020, 2013.

I. N. Crispe, Immune tolerance in liver disease, Hepatology, vol.60, pp.2109-2117, 2014.

A. I. Jacob, P. K. Goldberg, N. Bloom, G. A. Degenshein, and P. J. Kozinn, Endotoxin and bacteria in portal blood, Gastroenterology, vol.72, pp.1268-1270, 1977.

P. A. Knolle and R. Thimme, Hepatic immune regulation and its involvement in viral hepatitis infection, Gastroenterology, vol.146, pp.1193-1207, 2014.

F. Heymann and F. Tacke, Immunology in the liver -from homeostasis to disease, Nat Rev Gastroenterol Hepatol, vol.13, pp.88-110, 2016.

P. Bertolino, D. G. Bowen, G. W. Mccaughan, . De-st-fazekas, and B. Groth, Antigenspecific primary activation of CD8+ T cells within the liver, J Immunol, vol.166, pp.5430-5438, 2001.

A. Warren, L. Couteur, D. G. Fraser, R. Bowen, D. G. Mccaughan et al., T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells, Hepatology, vol.44, pp.1182-1190, 2006.

L. Stross, J. Günther, G. Gasteiger, T. Asen, S. Graf et al., Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice, Hepatology, vol.56, pp.873-883, 2012.

A. C. Nathwani, U. M. Reiss, E. Tuddenham, C. Rosales, P. Chowdary et al., Long-term safety and efficacy of factor IX gene therapy in hemophilia B, N Engl J Med, vol.371, pp.1994-2004, 2014.

S. Lüth, S. Huber, C. Schramm, T. Buch, S. Zander et al., Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs, J Clin Invest, vol.118, pp.3403-3410, 2008.

M. Akbarpour, K. S. Goudy, A. Cantore, F. Russo, F. Sanvito et al., Insulin B chain 9-23 gene transfer to hepatocytes protects from type 1 diabetes by inducing Ag-specific FoxP3+ Tregs, Sci Transl Med, vol.7, pp.289-81, 2015.

J. Cany, A. A. Pichard, V. , A. D. Ferry, N. Conchon et al., A transgenic mouse with b-Galactosidase as a fetal liver self-antigen for immunotherapy studies, J Hepatol, vol.47, pp.396-403, 2007.

H. Mai, F. Boeffard, J. Longis, R. Danger, B. Martinet et al., IL-7 receptor blockade following T cell depletion promotes long-term allograft survival, J Clin Invest, vol.124, pp.1723-1733, 2014.
DOI : 10.1172/jci66287

URL : http://europepmc.org/articles/pmc3973119?pdf=render

P. O. Seglen, Preparation of isolated rat liver cells, Methods Cell Biol, vol.13, pp.29-83, 1976.

V. Gauttier, J. Judor, L. Guen, V. Cany, J. Ferry et al., Agonistic anti-CD137 antibody treatment leads to antitumor response in mice with liver cancer, Int J Cancer, vol.135, pp.2857-2867, 2014.

X. Jiang, C. Shen, J. Rey-ladino, H. Yu, and R. C. Brunham, Characterization of murine dendritic cell line JAWS II and primary bone marrow-derived dendritic cells in Chlamydia muridarum antigen presentation and induction of protective immunity, Infect Immun, vol.76, pp.2392-2401, 2008.

S. Urbani, B. Amadei, D. Tola, M. Massari, S. Schivazappa et al., PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCVspecific CD8 exhaustion, J Virol, vol.80, pp.11398-11403, 2006.

D. Zehn, D. T. Utzschneider, and R. Thimme, Immune-surveillance through exhausted effector T-cells, Curr Opin Virol, vol.16, pp.49-54, 2016.
DOI : 10.1016/j.coviro.2016.01.002

E. J. Wherry, S. Ha, S. M. Kaech, W. N. Haining, S. Sarkar et al., Molecular signature of CD8+ T cell exhaustion during chronic viral infection, Immunity, vol.27, pp.670-684, 2007.

F. Mingozzi, Y. Liu, E. Dobrzynski, A. Kaufhold, J. H. Liu et al., Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer, J Clin Invest, vol.111, pp.1347-1356, 2003.

B. D. Brown, M. A. Venneri, A. Zingale, S. Sergi, L. Naldini et al., Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer, Nat Med, vol.12, pp.585-591, 2006.

E. Breous, S. Somanathan, L. H. Vandenberghe, and J. M. Wilson, Hepatic regulatory T cells and Kupffer cells are crucial mediators of systemic T cell tolerance to antigens targeting murine liver, Hepatology, vol.50, pp.612-621, 2009.

O. Murillo, D. M. Luqui, C. Gazquez, D. Martinez-espartosa, I. Navarro-blasco et al., Long-term metabolic correction of Wilson's disease in a murine model by gene therapy, J Hepatol, vol.64, pp.419-426, 2016.

E. C. Cunningham, S. S. Tay, C. Wang, M. Rtshiladze, Z. Z. Wang et al., Gene therapy for tolerance: high-level expression of donor major histocompatibility complex in the liver overcomes naive and memory alloresponses to skin grafts, Transplantation, vol.95, pp.70-77, 2013.

M. Cooper, S. Nayak, B. E. Hoffman, C. Terhorst, O. Cao et al., Improved induction of immune tolerance to factor IX by hepatic AAV-8 gene transfer, Hum Gene Ther, vol.20, pp.767-776, 2009.

M. Isogawa, J. Chung, Y. Murata, K. Kakimi, and F. V. Chisari, CD40 activation rescues antiviral CD8+ T cells from PD-1-mediated exhaustion, PLoS Pathog, vol.9, p.1003490, 2013.
DOI : 10.1371/journal.ppat.1003490

URL : https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1003490&type=printable

O. Hamid and R. D. Carvajal, Anti-programmed death-1 and anti-programmed death-ligand 1 antibodies in cancer therapy, Expert Opin Biol Ther, vol.13, pp.847-861, 2013.
DOI : 10.1517/14712598.2013.770836

M. Vo, L. E. Holz, Y. C. Wong, K. English, V. Benseler et al., The extent and duration of acute hepatitis in mice is dominated by the function rather than by the survival of effector CD8 T cells, J Hepatol, vol.2016, pp.1-43

M. J. Fuller, B. Callendret, B. Zhu, G. J. Freeman, D. L. Hasselschwert et al., Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1), Proc Natl Acad Sci U S A, vol.110, pp.15001-15006, 2013.

D. Gardiner, J. Lalezari, E. Lawitz, M. Dimicco, R. Ghalib et al., A randomized, double-blind, placebo-controlled assessment of BMS-936558, a fully human monoclonal antibody to programmed death-1 (PD-1), in patients with chronic hepatitis C virus infection, PLoS One, vol.8, p.63818, 2013.

E. J. Wherry and M. Kurachi, Molecular and cellular insights into T cell exhaustion, Nat Rev Immunol, vol.15, pp.486-499, 2015.

E. J. Wherry, T cell exhaustion, Nat Immunol, vol.12, pp.492-499, 2011.

H. Shin, S. D. Blackburn, J. N. Blattman, and E. J. Wherry, Viral antigen and extensive division maintain virus-specific CD8 T cells during chronic infection, J Exp Med, vol.204, pp.941-949, 2007.

W. Liu, A. L. Putnam, Z. Xu-yu, G. L. Szot, M. R. Lee et al., CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells, J Exp Med, vol.203, pp.1701-1711, 2006.

H. Kim, R. A. Barnitz, T. Kreslavsky, F. D. Brown, H. Moffett et al., Stable inhibitory activity of regulatory T cells requires the transcription factor Helios, Science, vol.350, pp.334-339, 2015.

H. Kim, B. Verbinnen, X. Tang, L. Lu, and H. Cantor, Inhibition of follicular T-helper cells by CD8(+) regulatory T cells is essential for self tolerance, Nature, vol.467, pp.328-332, 2010.

Z. Dai, S. Zhang, Q. Xie, S. Wu, J. Su et al., Natural CD8+CD122+ T cells are more potent in suppression of allograft rejection than CD4+CD25+ regulatory T cells, Am J Transplant, vol.14, pp.39-48, 2014.

N. Gagliani, T. Jofra, A. Stabilini, A. Valle, M. Atkinson et al., Antigen-specific dependence of Tr1-cell therapy in preclinical models of islet transplant, Diabetes, vol.59, pp.433-439, 2010.

A. R. Kendal and H. Waldmann, Infectious tolerance: therapeutic potential, Curr Opin Immunol, vol.22, pp.560-565, 2010.

G. Benichou, Direct and indirect antigen recognition: the pathways to allograft immune rejection, Front Biosci, vol.4, pp.476-480, 1999.

A. Zaiss, Q. Liu, G. P. Bowen, N. Wong, J. S. Bartlett et al., Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors, J Virol, vol.76, pp.4580-4590, 2002.

S. S. Tay, Y. C. Wong, D. M. Mcdonald, N. Wood, B. Roediger et al., Antigen expression level threshold tunes the fate of CD8 T cells during primary hepatic immune responses, Proc Natl Acad Sci U S A, vol.111, pp.2540-2549, 2014.

Y. C. Wong, S. S. Tay, G. W. Mccaughan, D. G. Bowen, and P. Bertolino, Immune outcomes in the liver: is CD8 T cell fate determined by the environment?, J Hepatol, vol.63, pp.1005-1014, 2015.

K. J. Wood and S. Sakaguchi, Regulatory T cells in transplantation tolerance, Nat Rev Immunol, vol.3, pp.199-210, 2003.

S. Kusaka, A. P. Grailer, J. H. Fechner, E. Jankowska-gan, T. Oberley et al., Clonotype analysis of human alloreactive T cells: a novel approach to studying peripheral tolerance in a transplant recipient, J Immunol, vol.164, pp.2240-2247, 2000.

C. Guillonneau, M. Hill, F. Hubert, E. Chiffoleau, C. Hervé et al., CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase, J Clin Invest, vol.117, pp.1096-1106, 2007.

C. J. Braun, K. Boztug, A. Paruzynski, M. Witzel, A. Schwarzer et al., Gene therapy for Wiskott-Aldrich syndrome-long-term efficacy and genotoxicity, Sci Transl Med, vol.6, pp.227-260, 2014.

L. Naldini, Gene therapy returns to centre stage, Nature, vol.526, pp.351-360, 2015.